Literature DB >> 13991706

Enzyme-alterable alkylating agents. IV. Treatment of cancer in children with repetitive massive doses of S-46, protecting the extremity marrow by tourniquets.

A SCHILLING.   

Abstract

Entities:  

Keywords:  BONE MARROW; EXTREMITIES; NEOPLASMS; NITROGEN MUSTARD COMPOUNDS

Mesh：

Substances：

Year:  1963        PMID： 13991706     DOI： 10.1002/1097-0142(196306)16:6<727::aid-cncr2820160607>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  1 in total

1.  Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second.

Authors:  L E Goodman; A Ulfohn; S P Kramer; E H Cendana; A B Flores; D Bakal; S J Abrams; R L Hirschfeld; S Calle; C E Williamson; S Sass; B Witten; A M Seligman
Journal:  Ann Surg       Date:  1965-10       Impact factor: 12.969
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.